Sort
40,608 grants matching “prostate cancer”
ONC201/TIC10 Anti-tumor Effect Through Regulation of the TRAIL pathway
$474,416Wafik S El-Deiry · Brown University · R01 · FY2022 · CA
ONC201/TIC10 Anti-tumor Effect Through Regulation of the TRAIL pathway
$474,416Wafik S El-Deiry · Brown University · R01 · FY2023 · CA
PATHOGENESIS OF HUMAN PROSTATE CARCINOMAS
$474,381University Of Southern California · R01 · FY2001 · CA
MECHANISMS OF EPITHELIAL CELL TUMORIGENESIS IN THE MOUSE
$474,367Terry A Van Dyke · Univ Of North Carolina Chapel Hill · R01 · FY2007 · CA
FATTY ACID SYNTHASE: STRUCTURE, DYNAMICS AND FUNCTION
$474,340Florante A Quiocho · Baylor College Of Medicine · R01 · FY2006 · GM
Community Outreach and Engagement
$474,319Erika S Trapl · Case Western Reserve University · P30 · FY2025 · CA
MECHANISMS OF EPITHELIAL CELL TUMORIGENESIS IN THE MOUSE
$474,305Terry A Van Dyke · Univ Of North Carolina Chapel Hill · R01 · FY2006 · CA
High Relaxivity PSMA-Targeted Contrast Agents for MRI of Prostate Cancer
$474,279Hans F. Schmitthenner · Rochester Institute Of Technology · R15 · FY2018 · CA
Mcl-1 in apoptosis and signal transduction: a structure/function approach
$474,252Maurizio Pellecchia · University Of California Riverside · R01 · FY2016 · CA
UDP-GLUCURONOSYLTRANSFERASE GENOTYPE AND CANCER RISK
$474,247Philip Lazarus · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2007 · DE
Image guided targeted biopsy of clinically significant prostate cancer with acoustic radiation force
$474,245Kathryn R Nightingale · Duke University · R01 · FY2021 · CA
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
$474,214David R Rowley · Baylor College Of Medicine · R01 · FY2019 · CA
Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens
$474,155Daniel William Cramer · Brigham And Women'S Hospital · R01 · FY2014 · CA
Gene Methylation in Prostate Cancer
$474,129Karen Woodson · Basic Sciences · Z01 · FY2007 · CA
The development of novel radiation-sensitizer based on ultra-small carbon dots
$474,089Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Exploring Collateral Lethality for Development of Cancer Therapeutics
$474,054Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Exploring Collateral Lethality for Development of Cancer Therapeutics
$474,053Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Cancer Recurrence: Detection in Administrative Data, Incidence, and Costs
$474,024Michael James Hassett · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Development Of Drugs Acting At Adenosine Receptors
$473,998Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Macro-to-micro (M2µ) Activity Apportionment for αRPT
$473,956Robert Francois Hobbs · Johns Hopkins University · P01 · FY2024 · CA
Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody
$473,941Paul Mathew · Tufts Medical Center · R01 · FY2021 · CA
Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody
$473,941Paul Mathew · Tufts Medical Center · R01 · FY2020 · CA
Greater Denver Latino Cancer Prevention/Control Network
$473,907Paula A Espinoza · University Of Colorado Denver/Hsc Denver · U01 · FY2007 · CA
HTS for TGF-beta receptor assembly inhibitors with anti-tumor and anti-fibrosis activities
$473,901Andrew P Hinck · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Computational Methods for Identifying Non-coding Cancer Drivers
$473,876Ekta Khurana · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA